Impact of diabetes mellitus on outcome after transcatheter aortic valve replacement: Identifying high-risk diabetic population from the OCEAN-TAVI registry.
Shingo MatsumotoYohei OhnoJunichi MiyamotoYuji IkariNorio TadaToru NaganumaMasahiro YamawakiFutoshi YamanakaShinichi ShiraiKazuki MizutaniMinoru TabataHiroshi UenoKensuke TakagiYusuke WatanabeMasanori YamamotoKentaro Hayashidanull nullPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)
Presence of DM was significantly associated with poor outcome after TAVR and adverse effect of DM was remarkable in patients with relatively higher LDL-C levels and reduced LVEF under 40%. These subtypes may need intensive control of cardiovascular risk factors, including DM, before and after TAVR.
Keyphrases
- transcatheter aortic valve replacement
- cardiovascular risk factors
- aortic stenosis
- aortic valve
- glycemic control
- transcatheter aortic valve implantation
- type diabetes
- cardiovascular disease
- metabolic syndrome
- emergency department
- adipose tissue
- wound healing
- heart failure
- atrial fibrillation
- low density lipoprotein